Risks of all-cause death and completed suicide in patients with schizophrenia/schizoaffective disorder treated with long-acting injectable or oral antipsychotics: A population-based retrospective cohort study in Taiwan

BACKGROUND: Long-acting injectable (LAI) antipsychotics improve medication adherence in patients with schizophrenia and extend the duration of therapeutic drug levels but with administration of an increased dose. Real-world mortality data in patients prescribed LAIs are lacking. We conducted a popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Chao-Hsiun, Shen, Shih-Pei, Huang, Min-Wei, Qiu, Hong, Watanabe, Sayuri, Goh, Choo Hua, Liu, Yanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853856/
https://www.ncbi.nlm.nih.gov/pubmed/34895379
http://dx.doi.org/10.1192/j.eurpsy.2021.2258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853856/
https://www.ncbi.nlm.nih.gov/pubmed/34895379
http://dx.doi.org/10.1192/j.eurpsy.2021.2258

Ejemplares similares